Silicon Valley Capital Partners’s Medtronic MDT Stock Holding History

Silicon Valley Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.6K	Buy	+30	New	+$2.87K	﹤0.01%	281
2025 Q4	–	Sell	-2	Closed	-$194	–	265
2025 Q3	$206	Sell	2 -2	-50%	-$184	﹤0.01%	275
2025 Q2	$320	Sell	4 -108	-96%	-$9.16K	﹤0.01%	296
2025 Q1	$9.81K	Sell	112 -23	-17%	-$2.06K	﹤0.01%	201
2024 Q4	$10.8K	Sell	135 -107,875	-100%	-$9.34M	﹤0.01%	248
2024 Q3	$9.72M	Buy	108,010 +653	+0.6%	+$54.9K	1.27%	20
2024 Q2	$8.45M	Buy	107,357 +13,303	+14%	+$1.09M	1.16%	24
2024 Q1	$8.2M	Buy	94,054 +21,584	+30%	+$1.84M	1.22%	23
2023 Q4	$5.97M	Buy	72,470 +6,162	+9%	+$470K	1%	24
2023 Q3	$5.2M	Buy	66,308 +19,784	+43%	+$1.66M	0.98%	24
2023 Q2	$4.1M	Buy	46,524 +6,920	+17%	+$596K	0.76%	21
2023 Q1	$3.19M	Buy	39,604 +2,089	+6%	+$170K	0.67%	23
2022 Q4	$2.92M	Buy	+37,515	New	+$3.04M	0.67%	18

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Silicon Valley Capital Partners's MDT Position: Q1 2026 in Review

Silicon Valley Capital Partners opened a new position in Medtronic (MDT) in Q1 2026: 30 shares worth $2.6K. The stake represents ﹤0.01% of the portfolio and ranks #281 among its holdings. This is a return to the name: Silicon Valley Capital Partners previously reported a position in MDT as recently as Q3 2025.

Silicon Valley Capital Partners first reported a position in MDT in Q4 2022 and has held it in 13 quarters since. The position peaked at $9.72M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Silicon Valley Capital Partners held 30 shares of Medtronic worth $2.6K as of Q1 2026.
Medtronic was a new Silicon Valley Capital Partners position in Q1 2026.
Medtronic made up ﹤0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #281 holding.
Silicon Valley Capital Partners first reported a position in Medtronic in Q4 2022 and has held it in 13 quarters since.
Silicon Valley Capital Partners's Medtronic position peaked at $9.72M in Q3 2024.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.